Madrid Expands RSV Vaccination to Adults Over 80

Here’s a breakdown of the medical conditions and age groups mentioned as indications for vaccination, based on the provided text:

Conditions/Situations Indicating Vaccination:

* HIV: Advanced HIV with CD4 count less than 200/μl.
* Hematopoietic Progenitor Transplantation: Patients undergoing this procedure.
* CAR-T Cell Therapy: Patients undergoing‍ this therapy, especially within two years of ‍treatment. Vaccination is also indicated if they receive⁢ immunosuppressive treatment or develop graft-versus-host disease, nonetheless of time since therapy.
* Dialysis: Patients on peritoneal or hemodialysis.
*⁣ ‍ Solid Organ Transplant: Patients with a solid ⁤organ transplant (especially lung transplant) and those on the waiting list.
*‍ Non-hematological Cancer: Patients undergoing active chemotherapy or immunosuppressive treatment within the last six months.

Age Group:

* 50 years old ‍and above: The Arexvy vaccine (against VRS) is currently authorized for administration in the Community of Madrid for individuals aged 50 years and older. There is a recommendation too expand this age range.